| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 93.0 | 78.2 | 65.6 |
| Other income | 3.2 | 1.9 | 1.7 |
| Total income | 96.2 | 80.1 | 67.4 |
| Profit before exceptional items & tax | 3.1 | 2.6 | 3.8 |
| Exceptional items | 0.0 | 0.2 | 0.2 |
| Profit before tax | 3.1 | 2.3 | 3.5 |
| Net profit | 1.6 | 2.3 | 1.4 |
| Operating margin | 3.2% | 2.9% | 5.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +14.30% |
|---|---|
| Net profit, quarter on quarter | -30.40% |
| Revenue, year on year | +41.80% |
NSE results filing, NSE: ZENITHDRUG. Figures extracted from the filing.
Zenith Drugs Ltd: key numbers
- Share price
- ₹42.15
- Market cap
- ₹72.28 Cr
- Revenue (annual)
- ₹171.2 Cr
- Net profit (annual)
- ₹3.94 Cr
- P/E (TTM)
- 18.3×Sector 47.4×
- Promoter holding
- 69.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Drugs Ltd
All →Zenith Drugs Annual General Meeting
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Board Meeting Outcome
Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.
Zenith Drugs Capital Structure Change
Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.
- Value
- ₹7.00 Cr
Zenith Drugs Annual General Meeting
Zenith Drugs Limited held an EGM on July 23, 2026. Members considered the issuance of up to 16,09,050 fully convertible warrants to promoters.
Zenith Drugs Annual General Meeting
Zenith Drugs issued a corrigendum to its EGM notice scheduled for July 23, 2026. Updates include details on a Rs. 36.58 Crore term loan and shareholding changes.
- Value
- ₹36.58 Cr
Zenith Drugs Annual General Meeting
Zenith Drugs Limited called an EGM on July 23, 2026. The meeting aims to approve issuing 16,09,050 convertible warrants to promoters.